Cardiovascular Systems Overview
- Year Founded
-
1989
- Status
-
Acquired/Merged
- Employees
-
725
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$851M
Cardiovascular Systems General Information
Description
Cardiovascular Systems Inc is a medical technology company focused on patients with peripheral and coronary artery diseases. Its peripheral artery disease systems are catheter-based platforms used to treat plaque in leg arteries above and below the knee. The firm's orbital atherectomy systems are used in peripheral and coronary commercial applications. Its OAS products include the Diamondback 360 Peripheral and Stealth 360 systems. Sales of Peripheral OAS contribute the majority of revenue. Cardiovascular systems generate the vast majority of its revenue in the United States.
Contact Information
Website
www.csi360.comCorporate Office
- 1225 Old Highway 8 Northwest
- Saint Paul, MN 55112
- United States
Corporate Office
- 1225 Old Highway 8 Northwest
- Saint Paul, MN 55112
- United States
Cardiovascular Systems Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 13. Merger/Acquisition | 27-Apr-2023 | $851M | Completed | Generating Revenue | ||
| 12. Secondary Transaction - Open Market | 31-Dec-2011 | Completed | Generating Revenue | |||
| 11. Secondary Transaction - Open Market | 31-Dec-2010 | Completed | Generating Revenue | |||
| 10. Reverse Merger | 25-Feb-2009 | Completed | Generating Revenue | |||
| 9. IPO | 06-Nov-2008 | Cancelled | Generating Revenue | |||
| 8. Later Stage VC (Series B) | 19-Dec-2007 | Completed | Generating Revenue | |||
| 7. Later Stage VC | 21-Sep-2007 | Completed | Generating Revenue | |||
| 6. Later Stage VC | 09-Oct-2006 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 31-Jul-2006 | $25M | $152M | Completed | Generating Revenue | |
| 4. Later Stage VC (Series D) | 29-Aug-2005 | $62.5M | $126M | Completed | Generating Revenue |
Cardiovascular Systems Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series D | ||||||||
| Series C | ||||||||
| Series B | 4,000,000 | $0.010000 | 8% | $1.25 | $1.25 | 1x | $1.25 | 3.49% |
| Series A | 13,140,000 | $0.010000 | 8% | $1 | $1 | 1x | $1 | 11.4% |
Cardiovascular Systems Comparisons
Industry
Financing
Details
Cardiovascular Systems Competitors (36)
One of Cardiovascular Systems’s 36 competitors is Atricure, a Formerly VC-backed company based in Mason, OH.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Atricure | Formerly VC-backed | Mason, OH | ||||
| Angiodynamics | Corporation | Latham, NY | ||||
| Teleflex | Corporation | Wayne, PA | ||||
| Jarvik Heart | Corporation | New York, NY | ||||
| Artivion | Formerly PE-Backed | Kennesaw, GA |
Cardiovascular Systems Patents
Cardiovascular Systems Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026236377-A1 | Peripheral intravascular lithotripsy system capable of use over 0.025 to 0.095-inch guidewire | Pending | 08-May-2025 | ||
| WO-2026198112-A1 | Cutting or scoring balloon with lithotripsy electrodes | Pending | 18-Mar-2025 | ||
| WO-2026198585-A1 | Non-sparking pulse for ivl catheter testing | Pending | 18-Mar-2025 | ||
| US-20260256483-A1 | Lithotripsy balloon dilation catheters having balloons to conform to lesions that are targeted by an acoustic or sound wave | Pending | 28-Feb-2025 | ||
| WO-2026183464-A1 | Lithotripsy balloon dilation catheters having balloons to conform to lesions that are targeted by an acoustic or sound wave | Pending | 28-Feb-2025 | A61B17/22022 |
Cardiovascular Systems Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Cardiovascular Systems Former Investors (16)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Easton Capital Investment Group | Venture Capital | Minority | ||
| GSK | Corporation | Minority | ||
| HealthCare Ventures | Venture Capital | Minority | ||
| JPB Partners | Asset Manager | Minority | ||
| Lumira Ventures | Venture Capital | Minority |
Cardiovascular Systems Investments & Acquisitions (8)
Cardiovascular Systems’s most recent deal was a Seed Round with Innova Vascular for . The deal was made on 01-Mar-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Innova Vascular | 01-Mar-2023 | Seed Round | Therapeutic Devices | ||
| CarePICS | 08-Apr-2021 | Merger/Acquisition | Enterprise Systems (Healthcare) | ||
| CarePICS | 08-Apr-2021 | Corporate | Enterprise Systems (Healthcare) | ||
| WavePoint (Peripheral Support Catheters) | 22-Mar-2021 | Corporate Asset Purchase | Buildings and Property | ||
| Gardia Medical (WIRION Embolic Protection System and Related Assets) | 05-Aug-2019 | Corporate Asset Purchase | Buildings and Property |
Cardiovascular Systems ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
20.25 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,585
Rank
Percentile
Healthcare
Industry
of 590
Rank
Percentile
Medical Devices
Subindustry
of 209
Rank
Percentile
Cardiovascular Systems FAQs
-
When was Cardiovascular Systems founded?
Cardiovascular Systems was founded in 1989.
-
Where is Cardiovascular Systems headquartered?
Cardiovascular Systems is headquartered in Saint Paul, MN.
-
What is the size of Cardiovascular Systems?
Cardiovascular Systems has 725 total employees.
-
What industry is Cardiovascular Systems in?
Cardiovascular Systems’s primary industry is Surgical Devices.
-
Is Cardiovascular Systems a private or public company?
Cardiovascular Systems is a Private company.
-
What is the current valuation of Cardiovascular Systems?
The current valuation of Cardiovascular Systems is .
-
What is Cardiovascular Systems’s current revenue?
The current revenue for Cardiovascular Systems is .
-
How much funding has Cardiovascular Systems raised over time?
Cardiovascular Systems has raised $183M.
-
Who are Cardiovascular Systems’s investors?
Easton Capital Investment Group, GSK, HealthCare Ventures, JPB Partners, and Lumira Ventures are 5 of 16 investors who have invested in Cardiovascular Systems.
-
Who are Cardiovascular Systems’s competitors?
Atricure, Angiodynamics, Teleflex, Jarvik Heart, and Artivion are some of the 36 competitors of Cardiovascular Systems.
-
When was Cardiovascular Systems acquired?
Cardiovascular Systems was acquired on 27-Apr-2023.
-
Who acquired Cardiovascular Systems?
Cardiovascular Systems was acquired by Abbott.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
